FDA Drugs (New Approvals & NDA)Original article
Fresenius Kabi Issues Voluntary Nationwide Recall of One Lot of Morphine Sulfate Injection, USP in a Simplist® Prefilled Syringe Due to Labeling Mix-up
RegulatoryMorphine Sulfate Injection, USP, Simplist® 2 mg/1 mLNegative
AI Analysis
Summary
Fresenius Kabi voluntarily recalled one lot of Morphine Sulfate Injection USP Simplist® 2 mg/1 mL due to a labeling mix-up where prefilled syringes labeled as morphine may contain incorrect contents. The recall was announced on August 4, 2026.
Outcome Details
Voluntary nationwide recall due to labeling mix-up; MicroVault labeled as Morphine 2 mg/1 mL may contain incorrect contents
Importance:5/10
Sentiment:
-0.80
product recalllabeling errorpatient safetymorphineinjectablevoluntary recall
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on August 5, 2026 5:35 PM